Drug Trial Radar · NCT04154293
A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
34
Actual
Start
Dec 3, 2019
Primary completion
Aug 20, 2021
Study completion Aug 30, 2021
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Nov 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the efficacy and safety of two concentrations of topically applied ointment formulation of isotretinoin called TMB-001 (0.05% and 0.1% isotretinoin) in subjects 9 years of age and older for the treatment of congenital ichthyosis (CI), including recessive X-linked ichthyosis (RXLI) and autosomal recessive congenital ichthyosis-lamellar ichthyosis (ARCI-LI) subtypes. Funding Source FDA-OOPD
Conditions
- Congenital Ichthyosis
Interventions
IsotretinoinDrug
Topical Isotretinoin ointment
VehicleOther
Topical Vehicle Ointment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Reduction in Targeted Ichthyosis Severity Using the Visual Index for Ichthyosis Severity MeasurementTime frame: 12 weeks
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialists
Phoenix, Arizona
Stanford University School of Medicine
Palo Alto, California
Yale Center for Clinical Investigation
New Haven, Connecticut
The Indiana Clinical Trials Center
Plainfield, Indiana
Austin Institute for Clinical Research, Inc
Metairie, Louisiana
Minnesota Clinical Study Center
New Brighton, Minnesota
Cincinnati Children's Hospital
Cincinnati, Ohio
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Queensland Children's Hospital
Brisbane, Queensland, Australia
Premier Specialists, The church
Kogarah, Sydney, Australia
Murdoch Children's Research Institute, RCH
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.